Brief: Spago Nanomedical Q3 Sales SEK 14 Thousand
Oct 29 (Reuters) - Spago Nanomedical Q3 net income SEK -6.265 million. Q3 adjusted EPS SEK -0.02 Q3 operating expenses SEK -7.568 million
Oct 29 (Reuters) - Spago Nanomedical Q3 net income SEK -6.265 million. Q3 adjusted EPS SEK -0.02 Q3 operating expenses SEK -7.568 million